US6407092B1
(en)
|
1999-04-23 |
2002-06-18 |
Pharmacia & Upjohn Company |
Tetracyclic azepinoindole compounds
|
US6552017B1
(en)
*
|
1999-06-15 |
2003-04-22 |
Bristol-Myers Squibb Pharma Company |
Substituted heterocycle fused gamma-carbolines
|
JP2004509893A
(ja)
|
2000-09-20 |
2004-04-02 |
ファルマシア・アンド・アップジョン・カンパニー |
置換型アゼピノ[4,5b]インドリン誘導体
|
US6759405B2
(en)
|
2000-11-03 |
2004-07-06 |
Wyeth |
Cycloocta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives
|
AR031202A1
(es)
|
2000-11-03 |
2003-09-10 |
Wyeth Corp |
Ciclopenta(b) (1,4)diazepino(6,7,1-hi) indoles y derivados
|
US6858604B2
(en)
|
2000-11-03 |
2005-02-22 |
Wyeth |
Cyclohepta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives
|
SE0004245D0
(sv)
|
2000-11-20 |
2000-11-20 |
Pharmacia Ab |
Novel compounds and their use
|
PL360982A1
(en)
|
2000-11-20 |
2004-09-20 |
Biovitrum Ab |
Piperazinylpyrazines compounds as antagonists of serotonin 5-ht2 receptor
|
US6849619B2
(en)
|
2000-12-20 |
2005-02-01 |
Bristol-Myers Squibb Company |
Substituted pyridoindoles as serotonin agonists and antagonists
|
RU2003121304A
(ru)
*
|
2000-12-20 |
2005-01-27 |
Бристол-Маерс Сквибб Компани (Us) |
Замещенные пиридоиндолы в качестве агонистов и антагонистов серотонина
|
ATE318821T1
(de)
*
|
2001-06-01 |
2006-03-15 |
Alcon Inc |
Pyranoindazole und ihre verwendung in der glaukombehandlung
|
JP2004532887A
(ja)
*
|
2001-06-01 |
2004-10-28 |
アルコン,インコーポレイテッド |
新規な融合インダゾールおよびインドールおよび緑内障治療へのこれらの使用
|
CN1512879A
(zh)
*
|
2001-06-01 |
2004-07-14 |
�Ƹ��� |
新的芳氨基丙烷类似物及其用于治疗青光眼的用途
|
MXPA04001202A
(es)
|
2001-08-06 |
2005-02-17 |
Pharmacia & Upjhon Company |
Ligandos tetraciclicos terapeuticamente utiles.
|
US20030060462A1
(en)
*
|
2001-08-06 |
2003-03-27 |
Hoffman Robert L. |
Therapeutic compounds
|
CA2460126A1
(en)
*
|
2001-09-21 |
2003-03-27 |
Pharmacia & Upjohn Company |
Tricyclic indole derivatives as 5-ht ligands
|
BR0213417A
(pt)
*
|
2001-10-18 |
2004-11-03 |
Upjohn Co |
Compostos e composições de tetraciclicazaindóis e indolinas tendo atividade de 5-ht e seus usos
|
TWI312781B
(en)
|
2002-04-25 |
2009-08-01 |
|
[1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents
|
TW200307682A
(en)
|
2002-04-25 |
2003-12-16 |
Wyeth Corp |
1,2,3,4,7,8-Hexahydro-6H-[1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents
|
TW200307540A
(en)
|
2002-04-25 |
2003-12-16 |
Wyeth Corp |
[1, 4]Diazocino[7, 8, 1-hi] indole derivatives as antipsychotic and antiobesity agents
|
CA2485537A1
(en)
|
2002-06-19 |
2003-12-31 |
Biovitrum Ab |
Novel compounds, their use and preparation
|
US6958420B2
(en)
*
|
2002-07-19 |
2005-10-25 |
Board Of Trustees Of Michigan State University |
Synthesis of aminoarylboronic esters and substituted anilines from arenes via catalytic C-H activation/borylation/amination and uses thereof
|
AU2003262931B2
(en)
*
|
2002-08-30 |
2008-06-26 |
Alcon, Inc. |
Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma
|
JP2006511556A
(ja)
|
2002-12-13 |
2006-04-06 |
アルコン,インコーポレイテッド |
新規のベンゾピラン類似体及び緑内障の治療のためのそれらの使用
|
US7109339B2
(en)
|
2002-12-19 |
2006-09-19 |
Bristol-Myers Squibb Company |
Substituted tricyclic gamma-carbolines as serotonin receptor agonists and antagonists
|
CL2004000826A1
(es)
|
2003-04-25 |
2005-03-04 |
Pfizer |
Uso de un agonista para el receptor 5-ht2c para preparar un medicamento util en el tratamiento de la incontinencia urinaria provocada por estres, con la condicion de que el agonista no sea 1-[6-cloro-5-(trifluorometil)-2-piridinil]piperazina (org-129
|
US7728155B2
(en)
|
2003-10-24 |
2010-06-01 |
Wyeth Llc |
Dihydrobenzofuranyl alkanamines and methods for using same as cns agents
|
US7476687B2
(en)
|
2003-11-26 |
2009-01-13 |
Alcon, Inc. |
Substituted furo[2,3-g]indazoles for the treatment of glaucoma
|
WO2005058911A2
(en)
|
2003-12-15 |
2005-06-30 |
Alcon, Inc. |
Substituted [1,4]oxazino[2,3-g]indazoles for the treatment of glaucoma
|
US7129257B1
(en)
|
2003-12-15 |
2006-10-31 |
Alcon, Inc. |
Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma
|
US7338972B1
(en)
|
2003-12-15 |
2008-03-04 |
Alcon, Inc. |
Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma
|
US8076353B2
(en)
|
2004-03-15 |
2011-12-13 |
Ptc Therapeutics, Inc. |
Inhibition of VEGF translation
|
AU2005222632B2
(en)
|
2004-03-15 |
2012-02-09 |
Ptc Therapeutics, Inc. |
Carboline derivatives useful in the inhibition of angiogenesis
|
US8076352B2
(en)
|
2004-03-15 |
2011-12-13 |
Ptc Therapeutics, Inc. |
Administration of carboline derivatives useful in the treatment of cancer and other diseases
|
US7767689B2
(en)
*
|
2004-03-15 |
2010-08-03 |
Ptc Therapeutics, Inc. |
Carboline derivatives useful in the treatment of cancer
|
WO2006009831A1
(en)
|
2004-06-18 |
2006-01-26 |
Wyeth |
Processes for preparing 6-alkyl-5-arylsulfonyl- dihydrophenanthridines
|
JP5173190B2
(ja)
|
2004-08-25 |
2013-03-27 |
武田薬品工業株式会社 |
腹圧性尿失禁の予防・治療剤及びそのスクリーニング方法
|
GT200500317A
(es)
|
2004-11-05 |
2006-10-27 |
|
Proceso para preparar compuestos de quinolina y productos obtenidos de los mismos
|
US7425572B2
(en)
|
2004-12-08 |
2008-09-16 |
Alcon, Inc. |
Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma
|
AR054849A1
(es)
|
2005-07-26 |
2007-07-18 |
Wyeth Corp |
Diazepinoquinolinas, sintesis de las mismas, e intermediarios para obtenerlas
|
WO2007084622A2
(en)
*
|
2006-01-19 |
2007-07-26 |
Athersys, Inc. |
Thiophenyl and pyrrolyl azepines as serotonin 5-ht2c receptor ligands and uses thereof
|
EP2018863B9
(en)
|
2006-05-16 |
2015-02-18 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic compound and use thereof
|
RU2009108280A
(ru)
|
2006-08-08 |
2010-09-20 |
Санофи-Авентис (Fr) |
Ариламиноарилалкилзамещенные имидазолидин-2,4-дионы, способы их получения, содержащие эти соединения лекарственные средства и их применение
|
KR101805914B1
(ko)
*
|
2007-03-12 |
2017-12-06 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
치환된 헤테로환 융합 감마-카르볼린 합성
|
CA2688161C
(en)
|
2007-06-04 |
2020-10-20 |
Kunwar Shailubhai |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
US20100266504A1
(en)
|
2007-11-15 |
2010-10-21 |
Takahiro Matsumoto |
Condensed pyridine derivative and use thereof
|
JP5501251B2
(ja)
*
|
2008-01-11 |
2014-05-21 |
アルバニー モレキュラー リサーチ, インコーポレイテッド |
Mch拮抗薬としての(1−アジノン)置換ピリドインドール類
|
KR20150140418A
(ko)
|
2008-03-12 |
2015-12-15 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
치환된 헤테로사이클 융합 감마-카볼라인 고체
|
AU2015218433B2
(en)
*
|
2008-05-27 |
2017-07-27 |
Intra-Cellular Therapies, Inc. |
Methods and compositions for sleep disorders and other disorders
|
CN102105059B
(zh)
*
|
2008-05-27 |
2015-09-30 |
细胞内治疗公司 |
用于睡眠障碍和其他疾病的方法和组合物
|
ES2522968T3
(es)
|
2008-06-04 |
2014-11-19 |
Synergy Pharmaceuticals Inc. |
Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
|
WO2010003624A2
(en)
|
2008-07-09 |
2010-01-14 |
Sanofi-Aventis |
Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
|
ES2624828T3
(es)
|
2008-07-16 |
2017-07-17 |
Synergy Pharmaceuticals Inc. |
Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
|
EP2344505A2
(en)
*
|
2008-09-29 |
2011-07-20 |
Abbott Laboratories |
Indole and indoline derivatives and methods of use thereof
|
US9625475B2
(en)
*
|
2008-09-29 |
2017-04-18 |
Abbvie Inc. |
Indole and indoline derivatives and methods of use thereof
|
WO2010068601A1
(en)
|
2008-12-08 |
2010-06-17 |
Sanofi-Aventis |
A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
|
US8629158B2
(en)
|
2009-07-01 |
2014-01-14 |
Albany Molecular Research, Inc. |
Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof
|
EP2448585B1
(en)
*
|
2009-07-01 |
2014-01-01 |
Albany Molecular Research, Inc. |
Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine mch-1 antagonists, methods of making, and use thereof
|
WO2011003021A1
(en)
*
|
2009-07-01 |
2011-01-06 |
Albany Molecular Research, Inc. |
Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
|
WO2011003012A1
(en)
|
2009-07-01 |
2011-01-06 |
Albany Molecular Research, Inc. |
Azinone-substituted azapolycycle mch-1 antagonists, methods of making, and use thereof
|
SG177523A1
(en)
|
2009-07-14 |
2012-02-28 |
Albany Molecular Res Inc |
5-ht3 receptor modulators, methods of making, and use thereof
|
WO2011023754A1
(en)
|
2009-08-26 |
2011-03-03 |
Sanofi-Aventis |
Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use
|
US8575186B2
(en)
|
2009-10-05 |
2013-11-05 |
Albany Molecular Research, Inc. |
Epiminocycloalkyl[b] indole derivatives as serotonin sub-type 6 (5-HT6) modulators and uses thereof
|
EP2510949A4
(en)
|
2009-12-11 |
2013-11-13 |
Astellas Pharma Inc |
THERAPEUTICS FOR FIBROMYALGIA
|
US9193728B2
(en)
*
|
2010-02-18 |
2015-11-24 |
Medivation Technologies, Inc. |
Fused tetracyclic pyrido [4,3-B] indole and pyrido [3,4-B] indole derivatives and methods of use
|
WO2011103433A1
(en)
|
2010-02-18 |
2011-08-25 |
Medivation Technologies, Inc. |
Pyrido[4,3-b]indole and pyrido[3,4-b]indole derivatives and methods of use
|
WO2011103485A1
(en)
|
2010-02-18 |
2011-08-25 |
Medivation Technologies, Inc. |
Fused tetracyclic pyrido[4,3-b]indole and pyrido[3,4-b]indole derivatives and methods of use
|
US8993572B2
(en)
*
|
2010-04-22 |
2015-03-31 |
Intra-Cellular Therapies, Inc. |
Pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines derivatives and [1,4]oxazino[2,3,4-hi]pyrido[4,3-b]indole derivatives
|
US20130267500A1
(en)
|
2010-09-01 |
2013-10-10 |
Arena Pharmaceuticals, Inc. |
5-ht2c receptor agonists in the treatment of disorders ameliorated by reduction of norepinephrine level
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
US8993765B2
(en)
|
2010-12-21 |
2015-03-31 |
Albany Molecular Research, Inc. |
Tetrahydro-azacarboline MCH-1 antagonists, methods of making, and uses thereof
|
WO2012088038A2
(en)
|
2010-12-21 |
2012-06-28 |
Albany Molecular Research, Inc. |
Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof
|
AU2012207335A1
(en)
|
2011-01-19 |
2013-07-25 |
Albany Molecular Research, Inc. |
Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-HT6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia
|
WO2012112961A1
(en)
|
2011-02-18 |
2012-08-23 |
Medivation Technologies, Inc. |
Compounds and methods of treating hypertension
|
CN108676076A
(zh)
|
2011-03-01 |
2018-10-19 |
辛纳吉制药公司 |
制备鸟苷酸环化酶c激动剂的方法
|
US8895547B2
(en)
|
2011-03-08 |
2014-11-25 |
Sanofi |
Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
|
EP2683699B1
(de)
|
2011-03-08 |
2015-06-24 |
Sanofi |
Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
WO2012120051A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
|
EP2683702B1
(de)
|
2011-03-08 |
2014-12-24 |
Sanofi |
Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
EP2683701B1
(de)
|
2011-03-08 |
2014-12-24 |
Sanofi |
Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
US8871758B2
(en)
|
2011-03-08 |
2014-10-28 |
Sanofi |
Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
|
WO2012120054A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
EP2683704B1
(de)
|
2011-03-08 |
2014-12-17 |
Sanofi |
Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
US8901114B2
(en)
|
2011-03-08 |
2014-12-02 |
Sanofi |
Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof
|
EP2567959B1
(en)
|
2011-09-12 |
2014-04-16 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
US11053245B2
(en)
|
2012-04-14 |
2021-07-06 |
Intra-Cellular Therapies, Inc. |
Methods
|
US10154988B2
(en)
|
2012-11-14 |
2018-12-18 |
The Johns Hopkins University |
Methods and compositions for treating schizophrenia
|
WO2014137848A1
(en)
*
|
2013-03-04 |
2014-09-12 |
Daya Drug Discoveries, Inc |
PENTACYCLIC PYRIDOINDOLOBENZ[b,d]AZEPINE DERIVATIVES AND USES THEREOF
|
EP2970384A1
(en)
|
2013-03-15 |
2016-01-20 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase and their uses
|
PT2968320T
(pt)
|
2013-03-15 |
2021-01-28 |
Intra Cellular Therapies Inc |
Compostos orgânicos
|
JP6606491B2
(ja)
|
2013-06-05 |
2019-11-13 |
シナジー ファーマシューティカルズ インコーポレイテッド |
グアニル酸シクラーゼcの超高純度アゴニスト、その作成および使用方法
|
WO2015066344A1
(en)
|
2013-11-01 |
2015-05-07 |
Arena Pharmaceuticals, Inc. |
5-ht2c receptor agonists and compositions and methods of use
|
EP3666271A1
(en)
*
|
2013-12-03 |
2020-06-17 |
Intra-Cellular Therapies, Inc. |
Miscrospheres comprising a plga matrix for medical use
|
EP3125892A4
(en)
|
2014-04-04 |
2017-12-27 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
EP3125893B1
(en)
|
2014-04-04 |
2023-09-20 |
Intra-Cellular Therapies, Inc. |
Deuterated heterocycle fused gamma-carbolines as antagonists of 5-ht2a receptors
|
US10526287B2
(en)
|
2015-04-23 |
2020-01-07 |
Constellation Pharmaceuticals, Inc. |
LSD1 inhibitors and uses thereof
|
EP3407888B1
(en)
*
|
2016-01-26 |
2020-12-30 |
Intra-Cellular Therapies, Inc. |
Pyridopyrroloquinoxaline compounds, their compositions and uses
|
EP3888656A1
(en)
|
2016-03-25 |
2021-10-06 |
Intra-Cellular Therapies, Inc. |
Deuterated heterocyclic gamma-carboline compounds and their use in the treatment or prophylaxis of a central nervous system disorder
|
JP6997718B2
(ja)
*
|
2016-03-28 |
2022-01-18 |
イントラ-セルラー・セラピーズ・インコーポレイテッド |
新規共結晶
|
JP2019513143A
(ja)
*
|
2016-03-28 |
2019-05-23 |
イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. |
新規塩類および結晶
|
JP2019510039A
(ja)
|
2016-03-28 |
2019-04-11 |
イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. |
新規組成物および方法
|
JP7013454B2
(ja)
|
2016-10-12 |
2022-02-15 |
イントラ-セルラー・セラピーズ・インコーポレイテッド |
アモルファス固体分散体
|
RS64889B1
(sr)
|
2016-10-26 |
2023-12-29 |
Constellation Pharmaceuticals Inc |
Inhibitori lsd1 i njihova medicinska upotreba
|
WO2018106916A1
(en)
*
|
2016-12-07 |
2018-06-14 |
Concert Pharmaceuticals, Inc. |
Deuterated quinoxaline compounds
|
WO2018126140A1
(en)
*
|
2016-12-29 |
2018-07-05 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
WO2018126143A1
(en)
*
|
2016-12-29 |
2018-07-05 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
MX2021013640A
(es)
|
2017-03-24 |
2022-08-31 |
Intra Cellular Therapies Inc |
Composiciones novedosas y metodos.
|
JP2020513023A
(ja)
|
2017-04-10 |
2020-04-30 |
ドクター・レディーズ・ラボラトリーズ・リミテッド |
ルマテペロンp−トシラートの非晶質形態および固体分散体
|
CA3071119A1
(en)
*
|
2017-07-26 |
2019-01-31 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
JP7224333B2
(ja)
|
2017-07-26 |
2023-02-17 |
イントラ-セルラー・セラピーズ・インコーポレイテッド |
有機化合物
|
US10513515B2
(en)
|
2017-08-25 |
2019-12-24 |
Biotheryx, Inc. |
Ether compounds and uses thereof
|
JP2020535231A
(ja)
*
|
2017-09-26 |
2020-12-03 |
イントラ−セルラー・セラピーズ・インコーポレイテッドIntra−Cellular Therapies, Inc. |
新規な塩および結晶
|
EP3717484A4
(en)
*
|
2017-11-27 |
2021-08-04 |
Egis Gyógyszergyár Zrt. |
PROCESS FOR THE PRODUCTION OF LUMATEPERON AND ITS SALT
|
US20210052600A1
(en)
|
2017-12-27 |
2021-02-25 |
Takeda Pharmaceutical Company Limited |
Therapeutic agents for stress urinary incontinence and incotinence of feces
|
CN112040940A
(zh)
|
2018-03-23 |
2020-12-04 |
细胞内治疗公司 |
有机化合物
|
WO2019241278A1
(en)
|
2018-06-11 |
2019-12-19 |
Intra-Cellular Therapies, Inc. |
Substituted heterocycle fused gamma-carbolines synthesis
|
CA3108304A1
(en)
|
2018-06-21 |
2019-12-26 |
Aquestive Therapeutics, Inc. |
System and method for making personalized individual unit doses containing pharmaceutical actives
|
CN109100437A
(zh)
*
|
2018-07-22 |
2018-12-28 |
邯郸学院 |
仲胺类抗抑郁药物的质谱检测方法
|
CA3106239A1
(en)
|
2018-07-27 |
2020-01-30 |
Biotheryx, Inc. |
Bifunctional compounds as cdk modulators
|
CA3108558A1
(en)
|
2018-08-31 |
2020-03-05 |
Intra-Cellular Therapies, Inc. |
Novel methods
|
BR112021003655A2
(pt)
|
2018-08-31 |
2021-05-18 |
Intra-Cellular Therapies, Inc. |
métodos novos
|
US11541002B2
(en)
|
2018-09-07 |
2023-01-03 |
Aquestive Therapeutics, Inc. |
Oral film compositions and dosage forms having precise active dissolution profiles
|
EP3887374A2
(en)
|
2018-11-27 |
2021-10-06 |
Teva Pharmaceuticals International GmbH |
Solid state forms of lumateperone salts and processes for preparation of lumateperone and salts thereof
|
BR112021011792A2
(pt)
*
|
2018-12-17 |
2021-08-31 |
Intra-Cellular Therapies, Inc. |
Composto orgânico
|
MX2021007141A
(es)
*
|
2018-12-17 |
2021-08-11 |
Intra Cellular Therapies Inc |
Sintesis de gamma-carbolinas fusionadas con heterociclo sustituido.
|
KR20210104834A
(ko)
*
|
2018-12-17 |
2021-08-25 |
인트라-셀룰라 써래피스, 인코퍼레이티드. |
치환된 헤테로사이클 융합 감마-카르볼린 합성
|
JP7377871B2
(ja)
|
2018-12-21 |
2023-11-10 |
イントラ-セルラー・セラピーズ・インコーポレイテッド |
有機化合物
|
CA3125777A1
(en)
*
|
2019-01-23 |
2020-07-30 |
Intra-Cellular Therapies, Inc. |
Methods of treating addiction
|
JP2022521789A
(ja)
|
2019-02-27 |
2022-04-12 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
脳障害を治療するためのアゼピノ-インドール及び他の複素環化合物
|
CA3134674A1
(en)
*
|
2019-04-04 |
2020-10-08 |
Intra-Cellular Therapies, Inc. |
Methods of treating neuropathic pain
|
US20210000822A1
(en)
|
2019-07-07 |
2021-01-07 |
Intra-Cellular Therapies, Inc. |
Novel methods
|
IL292487A
(en)
|
2019-11-01 |
2022-06-01 |
Aquestive Therapeutics Inc |
Compositions of medicinal meters and methods of treatment
|
WO2021097247A1
(en)
|
2019-11-14 |
2021-05-20 |
Aquestive Therapeutics, Inc. |
Multimodal compositions and methods of treatment
|
WO2021119334A1
(en)
*
|
2019-12-11 |
2021-06-17 |
Intra-Cellular Therapies, Inc. |
Organic compound
|
WO2021222150A2
(en)
|
2020-04-28 |
2021-11-04 |
Anwita Biosciences, Inc. |
Interleukin-2 polypeptides and fusion proteins thereof, and their pharmaceutical compositions and therapeutic applications
|
KR20230054417A
(ko)
*
|
2020-10-09 |
2023-04-24 |
슈징 바이오파마 컴퍼니 리미티드 |
헤테로사이클로로 치환된 융합 γ-카르볼린 유도체, 이의 제조 방법, 중간체 및 용도
|
CN112062767B
(zh)
*
|
2020-10-20 |
2022-03-11 |
杭州科巢生物科技有限公司 |
一种卢美哌隆的制备方法及其中间体
|
CA3208345A1
(en)
|
2021-01-15 |
2022-07-21 |
Aquestive Therapeutics, Inc. |
Prodrug compositions and methods of treatment
|
US20220347117A1
(en)
|
2021-03-09 |
2022-11-03 |
Aquestive Therapeutics, Inc. |
Dosage forms having equivalent biocomparable profiles
|
CN116444520A
(zh)
*
|
2022-01-14 |
2023-07-18 |
上海科技大学 |
并环哌啶类化合物及其制备方法和用途
|
CN114456149A
(zh)
*
|
2022-02-24 |
2022-05-10 |
中国科学技术大学 |
一种多巴胺drd2受体拮抗剂及其用途
|
WO2023178111A2
(en)
*
|
2022-03-14 |
2023-09-21 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
WO2023178113A2
(en)
*
|
2022-03-14 |
2023-09-21 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
US20230372336A1
(en)
|
2022-05-18 |
2023-11-23 |
Intra-Cellular Therapies, Inc. |
Novel methods
|